Yahoo
Jakarta - Delayed Quote IDR

PT Darya-Varia Laboratoria Tbk (DVLA.JK)

1,570.00 0.00 (0.00%)
At close: October 30 at 3:48:42 PM GMT+7
Chart Range Bar
Loading chart for DVLA.JK
  • Previous Close 1,570.00
  • Open 1,575.00
  • Bid --
  • Ask --
  • Day's Range 1,560.00 - 1,575.00
  • 52 Week Range 1,420.00 - 1,695.00
  • Volume 7,500
  • Avg. Volume 35,453
  • Market Cap (intraday) 1.758T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 12.95
  • EPS (TTM) 121.25
  • Earnings Date --
  • Forward Dividend & Yield 128.00 (8.15%)
  • Ex-Dividend Date Jun 30, 2026
  • 1y Target Est --

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.

www.darya-varia.com

1,323

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

DVLA.JK
0.87%
IDX COMPOSITE (^JKSE)
41.52%

1-Year Return

DVLA.JK
1.47%
IDX COMPOSITE (^JKSE)
38.21%

3-Year Return

DVLA.JK
1.06%
IDX COMPOSITE (^JKSE)
24.92%

5-Year Return

DVLA.JK
16.90%
IDX COMPOSITE (^JKSE)
23.28%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.80%

  • Return on Assets (ttm)

    4.71%

  • Return on Equity (ttm)

    9.23%

  • Revenue (ttm)

    2.45T

  • Net Income Avi to Common (ttm)

    142.29B

  • Diluted EPS (ttm)

    121.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    360.76B

  • Total Debt/Equity (mrq)

    0.00%

  • Levered Free Cash Flow (ttm)

    5.14B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: